CAIHF (CPBIO Holding Co) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAIHF CPBIO Holding Co Ltd CAIHF
58 GF Score
Price $1.07
GF Value $0.16
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CPBIO Holding Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CPBIO Holding Co  (OTCPK:CAIHF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


CPBIO Holding Co Cyclically Adjusted PS Ratio Related Terms


CPBIO Holding Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for CPBIO Holding Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CPBIO Holding Co Cyclically Adjusted PS Ratio Chart

CPBIO Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.25 0.00 0.02 0.39

CPBIO Holding Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.40 0.38 0.37 0.35

CAIHF vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CPBIO Holding Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CPBIO Holding Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CPBIO Holding Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CPBIO Holding Co's Cyclically Adjusted PS Ratio falls into.


CAIHF
58GF Score
CPBIO Holding Co Ltd CAIHF
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CPBIO Holding Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

CPBIO Holding Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, CPBIO Holding Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.444/116.0564*116.0564
=0.444

Current CPI (Jun. 2026) = 116.0564.

CPBIO Holding Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.086 102.400 0.097
201612 0.106 102.600 0.120
201703 0.074 103.200 0.083
201706 0.053 103.100 0.060
201709 0.076 104.100 0.085
201712 0.107 104.500 0.119
201803 0.099 105.300 0.109
201806 0.078 104.900 0.086
201809 0.093 106.600 0.101
201812 0.118 106.500 0.129
201903 0.107 107.700 0.115
201906 0.103 107.700 0.111
201909 0.103 109.800 0.109
201912 0.124 111.200 0.129
202003 0.107 112.300 0.111
202006 0.088 110.400 0.093
202009 0.096 111.700 0.100
202012 0.093 111.500 0.097
202103 0.141 112.662 0.145
202106 0.109 111.769 0.113
202109 0.139 112.215 0.144
202112 0.173 113.108 0.178
202203 0.154 114.335 0.156
202206 0.166 114.558 0.168
202209 0.164 115.339 0.165
202212 0.144 115.116 0.145
202303 0.172 115.116 0.173
202306 0.155 114.558 0.157
202309 0.153 115.339 0.154
202312 0.207 114.781 0.209
202403 0.216 115.227 0.218
202406 0.210 114.781 0.212
202409 0.247 115.785 0.248
202412 0.542 114.893 0.547
202503 0.651 115.116 0.656
202506 0.625 114.907 0.631
202509 0.423 115.471 0.425
202512 0.416 115.832 0.417
202603 0.391 116.303 0.390
202606 0.444 116.056 0.444

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is CPBIO Holding Co (CAIHF) Overvalued in 2026?

Based on GuruFocus' analysis, CPBIO Holding Co stock appears to be overvalued. The current stock price of $1.07 is trading 567.3% above its estimated GF Value™ of $0.16. GuruFocus considers CPBIO Holding Co to be Significantly Overvalued.

Key valuation signals for CAIHF:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $0.16 vs. price of $1.07 (567.3% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the CAIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CPBIO Holding Co Business Description

Other Exchanges 03839:Hong Kong
Address 16 Harcourt Road, 21st Floor, Far East Finance Centre, Central, Hong Kong, HKG
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of animal health products and chlortetracycline (CTC). The group has two reportable segments: Biotech Business and Investment Business. The Biotech Business segment is involved in the manufacture and/or sale of animal health products and chlortetracycline. The Investment Business segment is engaged in the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. It generates the majority of its revenue from the Biotech Business segment. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.
58GF Score

Get the complete analysis for CAIHF

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.07
Price
$0.16
GF Value